SA

Shilpa Ankushrao Jagadale

Active Director Director DIN 07394848
DIN 07394848 First appointment Feb 2016 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Shilpa Ankushrao Jagadale

Data last updated:

Shilpa Ankushrao Jagadale is a Director at Jadhav Healthcare Private Limited (since 2016). The company operates in Chemicals.

DIN 07394848
Primary Designation Director
Industry Chemicals
First Appointment 11 Feb 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jadhav Healthcare Private Limited U24233PN2016PTC158343
Director11 Feb 20162016Active

Board colleagues of Shilpa Ankushrao Jagadale

NameDINCompanyDesignation
Rohit Sadashiv Jadhav07394847Jadhav Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Jadhav Healthcare Private Limited
Premium access

Shareholding and investment profile for Shilpa Ankushrao Jagadale

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shilpa Ankushrao Jagadale

Shilpa Ankushrao Jagadale currently holds 1 directorship: Jadhav Healthcare Private Limited (Director, since 11 Feb 2016).

Shilpa Ankushrao Jagadale was first appointed on 11 Feb 2016 as Director at Jadhav Healthcare Private Limited.

The current boards of Shilpa Ankushrao Jagadale's companies include Rohit Sadashiv Jadhav (Jadhav Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available